Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility & Validation of the Augmented Reality-Delivered GlenxRose Programs for Acquired Brain Injury

NCT05897593 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT05897593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility & Validation of the Augmented Reality-Delivered GlenxRose Programs for Acquired Brain Injury
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired brain injury, stroke, traumatic brain injury